ATLANTA, Nov. 9, 2023 /PRNewswire/ -- Today, Peach State Health Plan, a care management organization that serves the needs of Georgians through a range of health insurance solutions and wholly owned subsidiary of Centene Corporation (NYSE: CNC), announced a new partnership with Pyx Health, a health care technology company, in a new initiative to combat social isolation, loneliness and depression in young Georgians.
With this launch, more than 305,000 Peach State Health Plan members ages 13 to 17 now have access to Pyx Health's interactive platform, evidence based screening and trained human support from young adults with shared life experience called ANDYs (Authentic, Nurturing, Dependable and Your friend) for loneliness and depression while proactively connecting them with critical resources to improve their overall health, resiliency and social supports.
"Peach State Health Plan is committed to finding innovative solutions that address whole health needs, which include physical, behavioral and social health," said Wade Rakes, President and Chief Executive Officer of Peach State Health Plan. "Loneliness and social isolation can take a significant toll on the overall health of any young person, fueling issues such as depression, anxiety and risk of suicide. By addressing root-cause mental and emotional challenges, we are taking preventative steps to mitigate mental health emergencies, improve health outcomes and continue to make a positive impact for our young Georgians."
Through the partnership, Pyx will provide Peach State Health Plan members access to local and national 24/7 crisis hotlines, health plan and community resources, and a menu of relevant, teen-focused content such as dating safety and cyberbullying. Members can access Pyx Health and connect to resources at any time of day, ensuring that they get the precise help they need the moment they need it. Pyx Health's staff are background-checked and certified to provide social support and are overseen by an independently licensed clinical professional.
"Pyx Health's vision is to tackle loneliness where it matters most, for everyone who needs it," said Cindy Jordan, founder and CEO of Pyx Health. "And our kids are among those who need it most. The Surgeon General has underlined the dire need for youth support in his recent report saying that 'youth mental health is the defining public health crisis of our time,' highlighting the role of loneliness and social isolation in contributing to teen depression. By example, the CDC reported that nearly 20% of teens surveyed in 2021 had considered suicide in the past year. We are honored to be a part of Peach State Health Plan's crucial mission to serve and support their vulnerable teens."
For additional questions and information, please visit www.pshpgeorgia.com.
ABOUT PEACH STATE HEALTH PLAN
Peach State Health Plan is a Care Management Organization that serves the needs of Georgians through a range of health insurance solutions. Peach State Health Plan serves the Medicaid and PeachCare for Kids® population in partnership with Georgia Families. The organization also focuses on under-insured and uninsured individuals through its federal insurance marketplace plan, Ambetter, and its Medicare Advantage Special Needs Plan. Peach State Health Plan is a wholly owned subsidiary of Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives. For more information visit www.pshp.com.
About Pyx Health
Pyx Health offers the first evidence-based, data-driven loneliness solution that effectively addresses society's critical loneliness epidemic. Pyx Health leverages scalable technology and skilled, compassionate peer-to-peer human support to effectively reduce loneliness. Pyx Health's unique approach improves mental health outcomes, mitigates loneliness-related physical health conditions, and ultimately reduces health care costs. For more information, visit us at www.pyxhealth.com and follow us on LinkedIn, Twitter and Facebook. Because no one gets better alone™.
Last Trade: | US$70.83 |
Daily Change: | -1.83 -2.52 |
Daily Volume: | 4,604,229 |
Market Cap: | US$37.260B |
August 29, 2024 July 26, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB